Correlation from undiluted vitreous cytokines of untreated central retinal vein occlusion with spectral domain optical coherence tomography

Open Ophthalmology Journal

Volumn 7, Issue , 2013, Pages 11-17

  Koss, M J ^a,b   Pfister, M ^a   Rothweiler, F ^a   Rejdak, R ^c,d   Ribeiro, R ^b   Cinatl, J ^b   Schubert, R ^a   Kohnen, T ^a   Koch, F H ^a  

^a GOETHE UNIVERSITY   (Germany)

^b DOHENY EYE INSTITUTE   (United States)

^c MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^d MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

CBA; CRVO; IL 6; MCP 1; SD OCT; VEGF; Vitreous samples

Indexed keywords

INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN A; CYTOKINE; VASCULOTROPIN;

AGED; ARTICLE; CENTRAL MACULAR THICKNESS; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOATERECTOMY; HUMAN; MALE; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA FOVEA; RETINA SURGERY; RETINAL THICKNESS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY; VITRECTOMY; FLUORESCENCE ANGIOGRAPHY; HYPERTENSION; IRIS FIXATED PHAKIC INTRAOCULAR LENS; ISCHEMIA; PIGMENT EPITHELIUM; RETINA MACULA CYSTOID EDEMA; RETINOPATHY; VITREOUS BODY;

EID: 84876093045     PISSN: None     EISSN: 18743641     Source Type: Journal    
DOI: 10.2174/1874364101307010011     Document Type: Article

References (21)

1. Tsujikawa A, Sakamoto A, Ota M, et al. Serous retinal detachment associated with retinal vein occlusion. Am J Ophthalmol 2010; 149(2): 291-301 e5.
2. Yamaike N, Tsujikawa A, Ota M, et al. Three-dimensional imaging of cystoid macular edema in retinal vein occlusion. Ophthalmology 2008; 115(2): 355-62 e2.
3. Ota M, Tsujikawa A, Kita M, et al. Integrity of foveal photoreceptor layer in central retinal vein occlusion. Retina 2008; 28(10): 1502-8.
4. Shin HJ, Chung H, Kim HC. Association between integrity of foveal photoreceptor layer and visual outcome in retinal vein occlusion. Acta Ophthalmologica 2011; 89(1): e35-40.
5. Kriechbaum K, Prager F, Geitzenauer W, et al. Association of retinal sensitivity and morphology during antiangiogenic treatment of retinal vein occlusion over one year. Ophthalmology 2009; 116(12): 2415-21.
6. Funk M, Kriechbaum K, Prager F, et al. Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab. Invest Ophthalmol Vis Sci 2009; 50(3): 1025-32.
7. Noma H, Funatsu H, Mimura T, Harino S, Hori S. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Ophthalmology 2009; 116(1): 87-93.
8. Noma H, Funatsu H, Mimura T, Shimada K. Increase of aqueous inflammatory factors in macular edema with branch retinal vein occlusion: a case control study. J Inflamm (Lond) 2010; 7: 44.
9. Jo N, Wu GS, Rao NA. Upregulation of chemokine expression in the retinal vasculature in ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 2003; 44(9): 4054-60.
10. Ryan SJ. Retina. 4th ed. In: Schachat AP, Ed. Philadelphia: MOSBY 2006.
11. Pe'er J, Folberg R, Itin A, Gnessin H, Hemo I, Keshet E. Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology 1998; 105(3): 412-6.
12. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 1996; 271(2): 736-41.
13. Noma H, Funatsu H, Mimura T, Eguchi S, Shimada K, Hori S. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Curr Eye Res 2011; 36(3): 256-63.
14. Noma H, Funatsu H, Mimura T, Eguchi S, Shimada K. Role of soluble vascular endothelial growth factor receptor-2 in macular oedema with central retinal vein occlusion. Br J Ophthalmol 2011; 95(6): 788-92.
15. Koss MJ, Pfister M, Rothweiler F, et al. Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion. Acta Ophthalmol 2012; 90(2): e98-e103.
16. Koss MJ, Naser H, Sener A, et al. Combination therapy in diabetic macular oedema and retinal vein occlusion - past and present. Acta Ophthalmol 2012; 90(6): 580-9
17. Horii T, Murakami T, Nishijima K, Sakamoto A, Ota M, Yoshimura N. Optical coherence tomographic characteristics of microaneurysms in diabetic retinopathy. Am J Ophthalmol 2010; 150(6): 840-8.
18. Schober A, Zernecke A. Chemokines in vascular remodeling. Thromb Haemost 2007; 97(5): 730-7.
19. Stefansson E. Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol 2009; 247(2): 147-63.
20. Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 1995; 113(12): 1538-44.
21. Ali MH, Schlidt SA, Chandel NS, Hynes KL, Schumacker PT, Gewertz BL. Endothelial permeability and IL-6 production during hypoxia: role of ROS in signal transduction. Am J Physiol 1999; 277(5 Pt 1): L1057-65.